Delivery Order SPE2DR25D7062-SPE2DR26FW9EA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,668.69 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2 units) on September 23, 2025, with completion due by September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and active through December 2026. The place of...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 1, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) valued at $3,391.20 with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract issued by the Medical Supply Chain, a division of the Defense Logistics Agency supporting the Department of Defense. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,938.89 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) on November 5, 2025, with completion targeted for November 6, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) with a ceiling value of $2,317.68. This is a firm fixed-price delivery order executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $8,167.84 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Narcan 4 mg nasal spray (2-count units). This firm fixed-price delivery order, which is expected to be completed by December 15, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was not set-aside and was...
- The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,355.00 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract involves no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.44 to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-pack units) on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's established Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) under a firm fixed-price contract valued at $8,582.41, with completion required by July 2, 2025. The order was competitively awarded without set-aside restrictions and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,355.00 firm fixed-price delivery order for Narcan 4 mg nasal spray (2-pack units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D7062Indefinite Delivery Contract
- SPE2DR25D7062-SPE2DR26FW9EADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) under a firm fixed-price contract with a ceiling value of $5,631.58. The delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of January 13, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical federal pharmaceutical distributor, supplying a broad portfolio of medications and medical supplies to military and veteran healthcare systems. The company's extensive experience with DLA includes delivering various therapeutic classes of pharmaceuticals, from specialty medications to vaccines and medical devices. This Narcan delivery order reflects the company's role in supporting emergency medical capabilities within the federal health system, providing access to this opioid antagonist for critical medical interventions across the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 12/14/25 |